Indian shares advance as authorities approve COVID-19 vaccine

Gulf Today Report

Kicking off the first trading week of the new year, Indian shares jumped on Monday as investors’ confidence boost following the approval of two coronavirus vaccine.

The blue-chip NSE Nifty 50 index rose 0.48% to 14,085.45 and the benchmark S&P BSE Sensex rose 0.40% to 48,058.70. 

READ MORE 

Asian stock advance, European shares rally as coronavirus vaccination campaign kicks off

Oil prices record gain as investors hope OPEC+ caps output

Gold prices climb as coronavirus cases soar

 Indian has the second-highest number of coronavirus infections globally. It approved the emergency use of AstraZeneca/Oxford University vaccine and another by local company Bharat Biotech.

Gaurav Garg, head of research at CapitalVia Global Research in Indore said, “more details (on India's vaccination plans) is coming out...it might take only 6-10 months for everybody to get vaccines.”